Roche builds strength in molecular diagnostics

Share this article:

Roche has scooped up DNA sequencing firm Genia Technologies, reports the Wall Street Journal. The deal includes $125 million in an upfront payment, and the WSJ notes Monday's deal synchs with its acquisition of the molecular diagnostics firm IQuum and Roche's efforts to bolster its standing in this diagnostics space.

Roche attempted a hostile takeover of San Diego-based DNA sequencing firm Illumina in 2012. Illumina CEO Jay Flatley rallied stockholders to reject the takeover.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs


Reimagining healthcare? We want to hear about it.
 
Submit nominations here for MM&M's first-ever list of the Top 40 Healthcare Transformers

Email Newsletters

MM&M inVISION

More in Business Briefs

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.